Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma

P. P. Sordillo, G. B. Magill, R. J. Gralla, R. B. Golbey

Research output: Contribution to journal › Article › peer-review

ASJC Scopus subject areas

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{570046b7330e4320aba7f2830212a160,

title = "Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma",

author = "Sordillo, {P. P.} and Magill, {G. B.} and Gralla, {R. J.} and Golbey, {R. B.}",

year = "1980",

language = "English (US)",

volume = "64",

pages = "1129--1130",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "10-11",

}

TY - JOUR

T1 - Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma

AU - Sordillo, P. P.

AU - Magill, G. B.

AU - Gralla, R. J.

AU - Golbey, R. B.

PY - 1980

Y1 - 1980

UR - http://www.scopus.com/inward/record.url?scp=0019270851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019270851&partnerID=8YFLogxK

M3 - Article

C2 - 6893950

AN - SCOPUS:0019270851

VL - 64

SP - 1129

EP - 1130

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 10-11

ER -